Bcl‐2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression andin vivoangiogenesis in a breast carcinoma line
- 1 April 2000
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 14 (5) , 652-660
- https://doi.org/10.1096/fasebj.14.5.652
Abstract
We have previously demonstrated that bcl-2 overexpression enhances the metastatic potential of the MCF7 ADR human breast cancer cell line resistant to adriamycin by inducing metastasis-associated p...Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (98/30/C/31)
This publication has 37 references indexed in Scilit:
- Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic miceOncogene, 1997
- Anti-cell death activity promotes pulmonary metastasis of melanoma cellsOncogene, 1997
- Angiogenesis and metastasisEuropean Journal Of Cancer, 1996
- Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.Journal of Clinical Investigation, 1996
- Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targetingBreast Cancer Research and Treatment, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 CellsPublished by Elsevier ,1995
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Relationships Between Cell Killing, Mutation Induction and DNA Damage in X-irradiated V79 Cells: The Influence of Oxygen and DMSOInternational Journal of Radiation Biology, 1991
- Proteolytic balance and capillary morphogenesisCell Differentiation and Development, 1990